直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Article

Laches Remains a Viable Defense for Unreasonable Delay in Suing for Patent Infringement

November 3, 2015

LES Insights

By John C. Paul; D. Brian Kacedon

Authored by D. Brian Kacedon, John C. Paul, and Xiaoxiao Xue



Abstract

Despite a recent Supreme Court case denying a laches defense for unreasonable delay in suing for copyright infringement, the Federal Circuit held that laches remains a viable defense for unreasonable delay in suing for patent infringement. The court also held that a laches defense for unreasonable delay in suing can prevent a permanent injunction but does not preclude an ongoing royalty, absent extraordinary circumstances.

 




For decades, laches has been available as a defense to the recovery of pre-suit damages in a patent infringement suit based on the plaintiff's delay and prejudice to the defendant. Last year, however, in Petrella v. Metro-Goldwyn Mayer, Inc.,1 the Supreme Court held that laches could not be used as a defense to bar a claim for copyright infringement where the plaintiff brought suit within the time allowed by the statute of limitations. In light of the Supreme Court's decision in Petrella, the active judges from the Federal Circuit decided to rehear en banc, a recent case where a panel of three Federal Circuit judges previously determined that laches was a viable defense to a claim of patent infringement given the statutory six-year limitation on damages for claims of infringement.



Background

SCA and First Quality are competitors for adult-incontinence products. In 2003, SCA sent a letter to First Quality asserting that some of its products infringed its U.S. patent. First Quality responded, saying that the patent was invalid in view of certain prior art, so SCA filed a request for ex parte reexamination, asking the United States Patent and Trademark Office (USPTO) to evaluate its patent claims in light of the prior art cited by First Quality. Four years later, in response to SCA's request, the USPTO confirmed the patentability of all of the original claims in the asserted patent. Both during and after the reexamination proceedings, First Quality invested heavily in its line of for adult-incontinence products. SCA did not file suit against First Quality until 2010—more than six years after SCA first contacted First Quality to accuse it of infringing the patent in question. In view of SCA's six-year delay in filing suit, the district court granted First Quality's motion and dismissed the suit based on laches.

After SCA appealed, a Federal Circuit panel affirmed the district court's opinion on laches. SCA subsequently filed a petition for rehearing en banc, asking the court to reconsider its ruling in light of the U.S. Supreme Court's recent decision regarding laches in a copyright case in the Petrella case.



The Federal Circuit's En banc Decision

The en banc Federal Circuit considered two questions: 1) whether its prior caselaw should be overruled to hold that the defense of laches is not applicable in patent infringement cases and 2) whether the defense of laches should be available under some circumstances to bar an entire infringement suit for either damages or injunctive relief.

In answering the first question, the en banc court distinguished patent law from copyright law. According to the court, Petrella eliminated a judicially created laches defense for copyright cases because Congress had already enacted a statute of limitations law for copyright cases. But in patent cases, a statute, 35 U.S.C. § 286, sets a time limit for the recovering legal remedies, and 35 U.S.C. § 282 codifies laches as a defense. The en banc court held, therefore, that Congress settled the first question by statute, and that the courts do not have authority to question the statute. Laches, therefore, remains a viable defense in patent law.

As to the second question—whether laches should be available to bar an entire infringement suit for either damages or injunctive relief—the court held that where a party unreasonably delays filing suit for patent infringement, courts might properly deny a patentee's request to permanently enjoin a defendant from conducting infringing activity, but that delay in exercising a patent right, without more, does not mean that the patentee abandoned its right to the invention. Therefore, a patentee guilty of laches typically does not surrender its right to an ongoing royalty, absent extraordinary circumstances.



Strategy and Conclusions

This decision affirms the continued viability of the laches defense to the recovery of pre-suit damages in a patent infringement suit. A patent owner should promptly assert its rights upon communicating with potential infringers.

This decision also confirms that the laches defense extends to permanent injunction relief—patentees might not be able to prevent infringing activities where it unreasonably delayed filing suit if it would unduly prejudice the defendant. A party threatened with a permanent injunction may consider laches as a potential defense.

 

Endnotes

1 The SCA Hygiene decision may be found at http://www.finnegan.com/files/upload/LES_Insights_Column/2015/SCAHygiene_v_FirstQualityBabyProducts_Enbancopinion.pdf.

 

Tags

laches, infringement

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Copyright

Related Industries

Consumer Goods and Services

Consumer Products

Related Offices

Washington, DC

Related Professionals

John C. Paul
Partner
Washington, DC
+1 202 408 4109
Email
D. Brian Kacedon
Partner
Washington, DC
+1 202 408 4301
Email

Copyright © Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm's clients.

Related Insights

Conference

2026 EDTX Bench Bar Conference

October 28-30, 2026

Fort Worth

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Charitable

TopGolf for the Troops 2026

June 11, 2026

Ashburn

Seminar

3rd AI, IP, & Legal Forum

June 6, 2026

Shangai

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP